The study included more than 400 adult patients with COVID-19 who were hospitalized between March and July. Patients were treated at the University of Maryland Medical Center in Baltimore and three other East Coast hospitals.
Aspirin use was also linked to a lower risk of patients being placed on a mechanical ventilator (44 percent decrease) and ICU admission (43 percent decrease,) compared to those who were not taking aspirin. Researchers did not find differences in major bleeding between aspirin users and non-aspirin users.
About 76 percent of patients (314) did not receive aspirin, while about 24 percent (98) received a low dose within 24 hours of admission or right before admission.
Researchers believe the findings are related to the aspirin’s blood thinning effects.
The study noted that a randomized controlled trial “is needed to assess whether a causal relationship exists between aspirin use and reduced lung injury and mortality in COVID-19 patients.”
More articles on patient safety:
Insurance type may affect quality of surgical care, study finds
Boston Children’s Hospital to end 2 intersex surgeries
Down syndrome linked to 10 times higher COVID-19 death risk, UK study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
